Methods and systems for disease treatment using electrical stimulation

US9895539B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9895539-B1
Application numberUS-201414300193-A
CountryUS
Kind codeB1
Filing dateJun 9, 2014
Priority dateJun 10, 2013
Publication dateFeb 20, 2018
Grant dateFeb 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.

First claim

Opening claim text (preview).

We claim: 1. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising: using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz; transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system; applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient. 2. The method of claim 1 wherein the changes reduce chronic pain in the patient. 3. The method of claim 1 wherein the changes include a change in a conductance of the fast sodium channel. 4. The method of claim 1 wherein the changes include a downregulation of the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient. 5. The method of claim 1 wherein the changes includes an attenuation of pathology-induced sodium channel activity. 6. The method of claim 1 wherein the changes include a normalization of pathological neural networks associated with fast sodium channel activity, expression, or both. 7. The method of claim 1 wherein the changes include a modulation of glial neuronal cell interaction. 8. The method of claim 1 wherein the changes include a reduction of glial cell activity by reducing an extracellular potassium level. 9. The method of claim 1 wherein a frequency of the electrical therapy signal affects NaV1.8, NaV1.9, or both NaV1.8 and NaV1.9 sodium channels over another, slower sodium channel. 10. The method of claim 9 , further comprising applying the therapy signal to increase an activity, expression, or both activity and expression of the slower sodium channel. 11. The method of claim 10 wherein the slower sodium channel includes a NaV1.3 channel. 12. The method of claim 1 wherein said changes include a decrease in a release, by glial cells, of at least one of nitric oxide, a proinflammatory cytokine, an excitatory amino acids, or a prostaglandin. 13. The method of claim 1 wherein the target neural population is at the patient's spinal cord. 14. The method of claim 1 wherein the target neural population is at a peripheral nerve of the patient. 15. The method of claim 1 wherein the changes include an increase in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient. 16. The method of claim 1 wherein the changes include a decrease in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient. 17. The method of claim 1 wherein the electrical therapy signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds. 18. The method of claim 1 wherein the electrical therapy signal has an amplitude in an amplitude range of 0.1 mA to 20 mA. 19. The method of claim 1 wherein the electrical therapy signal has a duty cycle in a duty cycle range of 5% to 75%. 20. The method of claim 1 wherein the electrical signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA. 21. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising: using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz, a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA; transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system; applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and wherein the electrical therapy signal treats chronic pain. 22. The method of claim 21 wherein the electrical therapy treats chronic back pain and wherein the target neural population is at a thoracic vertebral level. 23. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising: using a signal generator to generate an electrical therapy signal having a pulse width in a pulse width range of 10 microseconds to 333 microseconds; transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system; applying the electrical therapy signal to the target neural population located in the patient's central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient. 24. The method of claim 23 wherein the changes produced by the electrical therapy signal reduce chronic pain in the patient. 25. The method of claim 23 wherein a frequency of the electrical therapy signal is in a range of 1.5 kHz to 100 kHz. 26. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising: using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz; transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient's central nervous system; and applying the electrical therapy signal to the target neural population, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and wherein the target neural population is remote from the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9895539B1 cover?
Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a freq…
Who is the assignee on this patent?
Nevro Corp, Nevro Corp
What technology area does this patent fall under?
Primary CPC classification A61N1/36071. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).